Flu Vaccine Industry Research Report 2024
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to APO Research, the global Flu Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Flu Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Flu Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.
The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Flu Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Flu Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Flu Vaccine Sales (2019-2030)
2.2.3 Global Flu Vaccine Market Average Price (2019-2030)
2.3 Flu Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Trivalent Influenza Vaccine
2.3.3 Quadrivalent Influenza Vaccine
2.4 Flu Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 For Children (6 months to 3 years)
2.4.3 For Adults and Children over 3 years
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Flu Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Flu Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Flu Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Flu Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Flu Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Flu Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Flu Vaccine, Product Type & Application
3.8 Global Manufacturers of Flu Vaccine, Date of Enter into This Industry
3.9 Global Flu Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Business Overview
4.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
4.1.5 Sanofi Pasteur Recent Developments
4.2 CSL
4.2.1 CSL Company Information
4.2.2 CSL Business Overview
4.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 CSL Flu Vaccine Product Portfolio
4.2.5 CSL Recent Developments
4.3 GSK
4.3.1 GSK Company Information
4.3.2 GSK Business Overview
4.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 GSK Flu Vaccine Product Portfolio
4.3.5 GSK Recent Developments
4.4 Mylan
4.4.1 Mylan Company Information
4.4.2 Mylan Business Overview
4.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Mylan Flu Vaccine Product Portfolio
4.4.5 Mylan Recent Developments
4.5 Hulan Bio
4.5.1 Hulan Bio Company Information
4.5.2 Hulan Bio Business Overview
4.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Hulan Bio Flu Vaccine Product Portfolio
4.5.5 Hulan Bio Recent Developments
4.6 AstraZeneca
4.6.1 AstraZeneca Company Information
4.6.2 AstraZeneca Business Overview
4.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 AstraZeneca Flu Vaccine Product Portfolio
4.6.5 AstraZeneca Recent Developments
4.7 CCBIO
4.7.1 CCBIO Company Information
4.7.2 CCBIO Business Overview
4.7.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 CCBIO Flu Vaccine Product Portfolio
4.7.5 CCBIO Recent Developments
5 GLOBAL FLU VACCINE MARKET SCENARIO BY REGION
5.1 Global Flu Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Flu Vaccine Sales by Region: 2019-2030
5.2.1 Global Flu Vaccine Sales by Region: 2019-2024
5.2.2 Global Flu Vaccine Sales by Region: 2025-2030
5.3 Global Flu Vaccine Revenue by Region: 2019-2030
5.3.1 Global Flu Vaccine Revenue by Region: 2019-2024
5.3.2 Global Flu Vaccine Revenue by Region: 2025-2030
5.4 North America Flu Vaccine Market Facts & Figures by Country
5.4.1 North America Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Flu Vaccine Sales by Country (2019-2030)
5.4.3 North America Flu Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Flu Vaccine Market Facts & Figures by Country
5.5.1 Europe Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Flu Vaccine Sales by Country (2019-2030)
5.5.3 Europe Flu Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Flu Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Flu Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Flu Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Flu Vaccine Market Facts & Figures by Country
5.7.1 Latin America Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Flu Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Flu Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Flu Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Flu Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Flu Vaccine Sales by Type (2019-2030)
6.1.1 Global Flu Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Flu Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Flu Vaccine Revenue by Type (2019-2030)
6.2.1 Global Flu Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Flu Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Flu Vaccine Sales by Application (2019-2030)
7.1.1 Global Flu Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Flu Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Flu Vaccine Revenue by Application (2019-2030)
7.2.1 Global Flu Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Flu Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Flu Vaccine Value Chain Analysis
8.1.1 Flu Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Flu Vaccine Production Mode & Process
8.2 Flu Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Flu Vaccine Distributors
8.2.3 Flu Vaccine Customers
9 GLOBAL FLU VACCINE ANALYZING MARKET DYNAMICS
9.1 Flu Vaccine Industry Trends
9.2 Flu Vaccine Industry Drivers
9.3 Flu Vaccine Industry Opportunities and Challenges
9.4 Flu Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Flu Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Flu Vaccine Sales (2019-2030)
2.2.3 Global Flu Vaccine Market Average Price (2019-2030)
2.3 Flu Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Trivalent Influenza Vaccine
2.3.3 Quadrivalent Influenza Vaccine
2.4 Flu Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 For Children (6 months to 3 years)
2.4.3 For Adults and Children over 3 years
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Flu Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Flu Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Flu Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Flu Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Flu Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Flu Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Flu Vaccine, Product Type & Application
3.8 Global Manufacturers of Flu Vaccine, Date of Enter into This Industry
3.9 Global Flu Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Business Overview
4.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
4.1.5 Sanofi Pasteur Recent Developments
4.2 CSL
4.2.1 CSL Company Information
4.2.2 CSL Business Overview
4.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 CSL Flu Vaccine Product Portfolio
4.2.5 CSL Recent Developments
4.3 GSK
4.3.1 GSK Company Information
4.3.2 GSK Business Overview
4.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 GSK Flu Vaccine Product Portfolio
4.3.5 GSK Recent Developments
4.4 Mylan
4.4.1 Mylan Company Information
4.4.2 Mylan Business Overview
4.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Mylan Flu Vaccine Product Portfolio
4.4.5 Mylan Recent Developments
4.5 Hulan Bio
4.5.1 Hulan Bio Company Information
4.5.2 Hulan Bio Business Overview
4.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Hulan Bio Flu Vaccine Product Portfolio
4.5.5 Hulan Bio Recent Developments
4.6 AstraZeneca
4.6.1 AstraZeneca Company Information
4.6.2 AstraZeneca Business Overview
4.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 AstraZeneca Flu Vaccine Product Portfolio
4.6.5 AstraZeneca Recent Developments
4.7 CCBIO
4.7.1 CCBIO Company Information
4.7.2 CCBIO Business Overview
4.7.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 CCBIO Flu Vaccine Product Portfolio
4.7.5 CCBIO Recent Developments
5 GLOBAL FLU VACCINE MARKET SCENARIO BY REGION
5.1 Global Flu Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Flu Vaccine Sales by Region: 2019-2030
5.2.1 Global Flu Vaccine Sales by Region: 2019-2024
5.2.2 Global Flu Vaccine Sales by Region: 2025-2030
5.3 Global Flu Vaccine Revenue by Region: 2019-2030
5.3.1 Global Flu Vaccine Revenue by Region: 2019-2024
5.3.2 Global Flu Vaccine Revenue by Region: 2025-2030
5.4 North America Flu Vaccine Market Facts & Figures by Country
5.4.1 North America Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Flu Vaccine Sales by Country (2019-2030)
5.4.3 North America Flu Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Flu Vaccine Market Facts & Figures by Country
5.5.1 Europe Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Flu Vaccine Sales by Country (2019-2030)
5.5.3 Europe Flu Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Flu Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Flu Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Flu Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Flu Vaccine Market Facts & Figures by Country
5.7.1 Latin America Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Flu Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Flu Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Flu Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Flu Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Flu Vaccine Sales by Type (2019-2030)
6.1.1 Global Flu Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Flu Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Flu Vaccine Revenue by Type (2019-2030)
6.2.1 Global Flu Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Flu Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Flu Vaccine Sales by Application (2019-2030)
7.1.1 Global Flu Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Flu Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Flu Vaccine Revenue by Application (2019-2030)
7.2.1 Global Flu Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Flu Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Flu Vaccine Value Chain Analysis
8.1.1 Flu Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Flu Vaccine Production Mode & Process
8.2 Flu Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Flu Vaccine Distributors
8.2.3 Flu Vaccine Customers
9 GLOBAL FLU VACCINE ANALYZING MARKET DYNAMICS
9.1 Flu Vaccine Industry Trends
9.2 Flu Vaccine Industry Drivers
9.3 Flu Vaccine Industry Opportunities and Challenges
9.4 Flu Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
